Latest article
Lilly’s tirzepatide beats Ozempic in head-to-head kind 2 diabetes trial
Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...
Greatest Health Gear Below $40: Greatest Price range Exercise Garments, Equipment
The products presented are selected independently by our editorial team. We can earn a commission on purchases made through our links. The...
5 Frequent Train Myths That Are Holding Again Your Health Targets
The fitness world is full of "experts" who like to give less than solid advice on what to and shouldn't do while exercising. ...